Epigral informs about investors presentation

27 Jan 2025 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Epigral has informed that it enclosed Investors Presentation of Un-Audited Financial Results – Q3 FY2025. The said Earnings Presentation is also available at www.epigral.com in the Investor Relations section.

The above information is a part of company’s filings submitted to BSE.

Epigral Share Price

1146.90 -11.25 (-0.97%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3610.90
Tata Chemicals 746.45
SRF 2958.20
Pidilite Inds. 1473.80
Deepak Nitrite 1535.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×